Changes in serum markers of oxidative stress with varying periods of haemodialysis

Nephrology

Volumn 9, Issue 2, 2004, Pages 77-82

  Köken, Tülay ^a   Serteser, Mustafa ^a   Kahraman, Ahmet ^a   Gökçe, Çigdem ^a   Demir, Serap ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

Haemodialysis; Oxidative stress; Protein carbonyls; Renal failure; Sulfhydryl; Thiobarbituric acid reactive substances; Uraemia

Indexed keywords

CARBONYL DERIVATIVE; MARKER; OXYGEN RADICAL; SCAVENGER; THIOBARBITURIC ACID; THIOL DERIVATIVE;

ADULT; ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SERUM; STATISTICAL ANALYSIS; TIME SERIES ANALYSIS; UREMIA;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS; SULFHYDRYL COMPOUNDS; THIOBARBITURATES;

EID: 1942467825     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2004.00240.x     Document Type: Article

References (42)

1. Dröge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002; 82: 47-95.
2. Durak I, Kacmaz M, Cimen MY et al. Blood oxidant/antioxidant status of atherosclerotic patients. Int. J. Cardiol. 2001; 77: 293-7.
3. Cerutti PA, Trump BF. Inflammation and oxidative stress in carcinogenesis. Cancer Cells 1991; 3: 1-7.
4. Bankson DD, Kestin M, Rifai N. Role of free radicals in cancer and atherosclerosis. Clin. Lab. Med. 1993; 13: 463-80.
5. Mimic-Oka J, Simic T, Djukanovic L et al. Alteration in plasma antioxidant capacity in various degrees of renal failure. Clin. Nephrol. 1999; 51: 233-41.
6. Himmelfarb J, McMonagle E, McMenamin E. Plasma protein thiol and carbonyl formation in chronic renal failure. Kidney Int. 2000; 58: 2571-8.
7. Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M et al. Gluthathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic. Biol. Med. 1996; 21: 845-53.
8. Miyata T, Saito A, Kurokawa K, van Ypersele de Strihou C. Advanced glycation and lipoxidation end products: Reactive carbonyl compounds-related uremic toxicity. Nephrol. Dial. Transplant. 2001; 16 (Suppl. 4): S8-11.
9. Inagi R & Miyata T. Oxidative protein damage with carbohydrates and lipids in uremia: Carbonyl stress. Blood Purif. 1999; 17: 95-8.
10. Zoccali C, Mallamaci F, Tripepi G. AGEs and carbonyl stress: Potential pathogenetic factors of long-term uraemic complications. Nephrol. Dial. Transplant. 2000; 15 (Suppl. 2): 7-11.
11. Schnackenberg CG. Oxygen radicals in cardiovascular-renal disease. Curr. Opin. Pharmacol. 2002; 2: 121-5.
12. Mathur S, Devaraj S, Jialal I. Accelerated atherosclerosis, dyslipidemia and oxidative stress in end-stage renal disease. Curr. Opin. Nephrol. Hypertens. 2002; 11: 141-7.
13. Köken T, Kahraman A, Serteser M, Çetinkaya G. Effects of hemodialysis on protein carbonyl content and sulfhydryl group levels. J. Turkish Soc. Nephrol. 2001; 10: 64-6 (in Turkish with an English abstract).
14. Donate T, Herreros A, Martinez E et al. Protein oxidative stress in dialysis patients. Adv. Perit. Dial. 2002; 18; 15-17.
15. Loughrey CM, Young IS, Lightbody JH et al. Oxidative stress in haemodialysis. QJM 1994; 87: 679-83.
16. Miyata T, Fu MX, Kurokawa K et al. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma. Is there oxidative stress in uremia? Kidney Int. 1998; 54: 1290-5.
17. Hörl WH. Hemodialysis membranes: Interleukins, biocompatibility, and middle molecules. J. Am. Soc. Nephrol. 2002; 13 (Suppl. 1): S62-71.
18. Morena M, Cristol J-P, Senécal L et al. Oxidative stress in hemodialysis patients: Is NADPH oxidase complex the culprit? Kidney Int. Suppl. 2002; 80: 109-14.
19. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxidase in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979; 95: 351-8.
20. Levine RL, Garland D, Oliver CN. Determination of carbonyl content in oxidatively modified proteins. Meth. Enzymol. 1990; 186: 464-78.
21. Koster JF, Biemond P, Swaak AJ. Intracellular and extracellular sulfhydryl levels in rheumatoid arthritis. Ann. Rheum. Dis. 1986; 45: 44-6.
22. Janssen YM, van Houten B, Borm PJ, Mossman BT. Cell and tissue responses to oxidative damage. Lab. Invest. 1993; 69: 261-74.
23. Stohs SJ. The role of free radicals in toxicity and disease. J. Basic Clin. Physiol. Pharmacol. 1995; 6: 205-28.
24. Gutteridge JMC. Lipid peroxidaiton and antioxidants as biomarkers of tissue damage. Clin. Chem. 1995; 41: 1819-1995.
25. Chevion M, Berenstein E, Stadtman ER. Human studies related to protein oxidation: Protein carbonyl content as a marker of damage. Free Radic. Res. 2000; 33: S99-108.
26. Thomas JA, Poland B, Honzatko R. Protein sulfhydryls and their role in the anti-oxidant function of protein S-thiolation. Arch. Biochem. Biophys. 1995; 319: 1-9.
27. Nguyen AT, Lethias C, Zingraff J et al. Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo within micro amounts of whole blood. Kidney Int. 1985; 28: 158-67.
28. Srinivasa RPV, Dakshinamurty KV, Saibaba KS et al. Oxidative stress in hemodialysis-intradialytic changes. Redox Rep. 2001; 6: 303-9.
29. Sela S, Shurtz-Swirski R, Shapiro G et al. Oxidative stress during hemodialysis: Effect of heparin. Kidney Int. 2001; 78: S159-63.
30. Himmelfarb J, McMenamin ME, Loseto G, Heinecke JW. Myeloperoxidase- catalyzed 3-chlorotyrosine formation in dialysis patients. Free Radic. Biol. Med. 2001; 31: 1163-9.
31. Matsuoka H. Endothelial dysfunction associated with oxidative stress in human. Diabetes Res. Clin. Pract. 2001; 54: S65-72.
32. Yoshimura S, Suemizu H, Nomoto Y et al. Plasma glutathione peroxidase deficiency caused by renal dysfunction. Nephron 1996; 73: 207-11.
33. Girelli D, Olivieri O, Stanzial AM et al. Low platelet glutathione peroxidase activity and serum selenium concentration in patients with chronic renal failure: Relationship between dialysis treatments, diet and cardiovascular complications. Clin. Sci. 1993; 84: 611-17.
34. Lim PS, Wei YH, Yu YL, Kho B. Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. Nephrol. Dial. Transplant. 1999; 14: 2680-7.
35. Nemeth I, Turi S, Haszon I, Berecczki C. Vitamin E alleviates the oxidative stress of erythropoitein in uremic children on hemodialysis. Pediatr. Nephrol. 2000; 14: 13-17.
36. Weinstein T, Chagnac A, Korzets A. Haemolysis in haemodialysis patients: Evidence for impaired defence mechanisms against oxidative stress. Nephrol. Dial. Transplant. 2000; 15: 883-7.
37. Nguyen-Khoa T, Massy ZA, de Bandt JP et al. Oxidative stress and hemodialysis: Role of inflammation and duration of dialysis treatment. Nephrol. Dial. Transplant. 2001; 16: 335-40.
38. Odetti P, Garibaldi S, Gurreri G et al. Protein oxidation in hemodialysis and kidney transplantation. Metabolism 1996; 45: 1319-22.
39. Miyata T, Ueda Y, Shinzato T, Lida Y, Tanaka S, Kurokawa K, van Ypersele de Strihou C. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients in end-stage renal failure: Renal implications in the pathophysiology of pentosidine. J. Am. Soc. Nephrol. 1996; 7: 1198-206.
40. Miyata T, Wada Y, Cai Z et al. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int. 1997; 51: 1170-81.
41. Miyata T, Ueda Y, Yasuda Y et al. Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: Carbonyl stress in uremia. J. Am. Soc. Nephrol. 1998; 9: 2349-56.
42. Odani H, Shinzato H, Matsumoto Y, Usami J, Maeda K. Increase in three α,β-dicarbonyl compound levels in human uremic plasma: Specific in vivo determination of intermediates in advanced Maillard reaction. Biochem. Biophys. Res. Commun. 1999; 256: 89-93.